FDA inspection
Mibo Medical Group: FDA inspection ending May 10, 2018
FDA inspection 1051389 · Official Action Indicated (OAI) · Dallas, TX
Key facts
| Inspection ID | 1051389 |
|---|---|
| Firm | Mibo Medical Group |
| FEI number | 3011407851 |
| Address | 2526 Manana Dr Ste 105 |
| City | Dallas |
| State | TX |
| ZIP | 75220 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | May 10, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
| Warning letter | 558900 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data